Lessons from Season 3
from Invent: Life Sciences Hosted by TTP plc
In Season 3 of Invent: Life Sciences, we explored the forces redefining how tomorrow’s therapies will be developed, made, and delivered. From the challenges of scaling cell and gene therapy manufacturing to the transformative power of sustainability and AI, this season uncovered what it truly takes to move from discovery to delivery. Featuring insights from leaders across Novartis, Cellular Origins, Orchard Therapeutics, Charles River, Cytiva, OmniaBio, Eli Lilly, and more, this season revealed how the biotech industry must evolve to make breakthrough therapies accessible, affordable, and ready for global deployment.
Embed this episode
No transcript yet.